ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #9,021Hybrid

Journal of Thrombosis and Thrombolysis

Acronym:thro
•
Abbreviation (ISO):J THROMB THROMBOLYS
•
Identifier (ISSN):0929-5305(Print)/1573-742X(Online)
•
Publisher:Springer US
Clarivate IF (2026)
2.1↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Thrombosis and Thrombolysis

WoS Q3
13572.6220182.9420192.0520202.320215.222022420232.320242.220252.12026
Annual Impact Factor Metric
Current (2026):2.1
Scopus SJR & RankScopus Q2
0.65
#9,021

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
86

86 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
239articles/year
31.91% Gold OA•85.27% Original Research

Aims & Scope

The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care. The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.

Topics Covered (Recognized by AI)
MedicineInternal medicine98.7%Psychology83.6%Psychiatry82.7%Biology80.8%Surgery68.1%Cardiology67.7%Immunology49.2%Chemistry45.8%Pathology44.2%Biochemistry42.6%Myocardial infarction31.1%Thrombosis30%Genetics26.6%Hematology26.1%Physics26%Intensive care medicine25.1%Platelet23.9%Mathematics23.7%Atrial fibrillation21.8%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q3
Rank138/237
IndexSCIE
JCRSCIE2026

HEMATOLOGY

Q3
Rank61/103
IndexSCIE
JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Q3
Rank57/100
IndexSCIE
JCISCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Q3
Rank122/237
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q2
Rank50/103
IndexSCIE
JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Q3
Rank56/100
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.1
Articles / Year161
Total Citations36
2025
IF2.2
Articles / Year159
Total Citations306
2024
IF2.3
Articles / Year139
Total Citations588
2023
IF4
Articles / Year167
Total Citations997
2022
IF5.221
Articles / Year142
Total Citations1,424

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,021Scopus Q2SCImago Profile
Scopus Coverage:1994-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.65

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.09

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,190 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,062
3-Year Documents513
Citable Documents476

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2
HematologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CARDIAC & CARDIOVASCULAR SYSTEMS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Thrombosis and Thrombolysis (acronym: thro, abbr: J THROMB THROMBOLYS, ISSN: 0929-5305) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in Netherlands since 1994. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.650 (Q2), an H-index of 86.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 239 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,190 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Bimonthly
Founding Year
1994
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: be7f8bc0-a8d1-41c0-9ba0-16ffdbeb3da0
Database Updated: 2026-09-28